Khiron Life Sciences Stock Performance
| KHRNF Stock | USD 0.0001 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Khiron Life are completely uncorrelated.
Risk-Adjusted Performance
12 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Khiron Life Sciences are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Khiron Life reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 21.6 M | |
| Total Cashflows From Investing Activities | -2.1 M |
Khiron |
Khiron Life Relative Risk vs. Return Landscape
If you would invest 0.01 in Khiron Life Sciences on September 3, 2024 and sell it today you would earn a total of 0.00 from holding Khiron Life Sciences or generate 0.0% return on investment over 90 days. Khiron Life Sciences is currently producing 28.125% returns and takes up 176.8048% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Khiron, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Khiron Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Khiron Life's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Khiron Life Sciences, and traders can use it to determine the average amount a Khiron Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1591
| Best Portfolio | Best Equity | KHRNF | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 176.8 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Khiron Life is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Khiron Life by adding it to a well-diversified portfolio.
Khiron Life Fundamentals Growth
Khiron Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Khiron Life, and Khiron Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Khiron Pink Sheet performance.
| Return On Equity | -0.75 | |||
| Return On Asset | -0.21 | |||
| Profit Margin | (1.90) % | |||
| Operating Margin | (1.08) % | |||
| Current Valuation | 9.19 M | |||
| Shares Outstanding | 216.39 M | |||
| Price To Book | 0.45 X | |||
| Price To Sales | 0.54 X | |||
| Revenue | 12.79 M | |||
| EBITDA | (32.03 M) | |||
| Cash And Equivalents | 5.82 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 705 K | |||
| Debt To Equity | 0.08 % | |||
| Book Value Per Share | 0.12 X | |||
| Cash Flow From Operations | (20.4 M) | |||
| Earnings Per Share | (0.15) X | |||
| Total Asset | 42.27 M | |||
About Khiron Life Performance
By analyzing Khiron Life's fundamental ratios, stakeholders can gain valuable insights into Khiron Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Khiron Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Khiron Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada. Khiron Life is traded on OTC Exchange in the United States.Things to note about Khiron Life Sciences performance evaluation
Checking the ongoing alerts about Khiron Life for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Khiron Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Khiron Life Sciences is way too risky over 90 days horizon | |
| Khiron Life Sciences has some characteristics of a very speculative penny stock | |
| Khiron Life Sciences appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 12.79 M. Net Loss for the year was (33.13 M) with profit before overhead, payroll, taxes, and interest of 6.37 M. | |
| Khiron Life Sciences has accumulated about 5.82 M in cash with (20.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Khiron Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Khiron Life's stock is overvalued or undervalued compared to its peers.
- Examining Khiron Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Khiron Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Khiron Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Khiron Life's pink sheet. These opinions can provide insight into Khiron Life's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Khiron Pink Sheet analysis
When running Khiron Life's price analysis, check to measure Khiron Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Khiron Life is operating at the current time. Most of Khiron Life's value examination focuses on studying past and present price action to predict the probability of Khiron Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Khiron Life's price. Additionally, you may evaluate how the addition of Khiron Life to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |